Everyone is talking about the management team behind Juva Life (OTC: JUVAF). 76.15% of the stock of Guardant Health is held by institutions. 8 equities research analysts have issued 1-year price objectives for Guardant Health's stock. Get short term trading ideas from the MarketBeat Idea Engine. Company insiders that own Guardant Health stock include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Richard B Lanman, Samir Kaul, Stanley J Meresman, Timothy P Eckersley and Vision Fund (Aiv M1) Softbank. GH:NASDAQ GS Stock Quote - Guardant Health Inc - Bloomberg Markets. The average price target represents a 1.09% upside from the last price of $111.78. Learn everything you need to know about successful options trading with this three-part video course. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. Guardant is selling 3,750,000 of the shares and SoftBank Investment Advisers is selling the other 7,750,000 shares. 3,668.10. View which stocks have been most impacted by COVID-19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Heâs agreed to share his secret with a small group of investors. View which stocks are hot on social media with MarketBeat's trending stocks report. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). GUARDANT HEALTH, INC. : Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, share GUARDANT HEALTH, INC. | … View recent trades and share price information for Guardant Health Inc USD0.00001 Guardant Health Inc quote is equal to 126.150 USD at 2020-12-09. Looking for new stock ideas? Guardant Health's mailing address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. In the past three months, Guardant Health insiders have sold more of their company's stock than they have bought. Only 9.90% of the stock of Guardant Health is held by insiders. Their average twelve-month price target is $121.86, predicting that the stock has a possible downside of 1.80%. (Add your “outperform” vote. The average price target is $113.00, with a high forecast of $130.00 and a low forecast of $100.00. The company has collaboration agreement with Radius Health, Inc. to develop liquid biopsy companion diagnostic for elacestrant. S&P 500. Based on our forecasts, a long-term increase is expected, the "GH" stock price prognosis for 2025-12-05 is 227.248 USD. Redwood City, CA 94063 Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. View insider buying and selling activity for Guardant Health or or view top insider-buying stocks. Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. View all competitors. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. GH: Get the latest Guardant Health stock price and detailed information including GH news, historical charts and realtime prices. Learn more. Learn about financial terms, types of investments, trading strategies and more. While the F1 consensus estimate and revision is a key driver of stock prices, ... Guardant Health Inc. is based in REDWOOD CITY, United States. Guardant Health employs 622 workers across the globe. GH stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Point72 Asset Management L.P., Railway Pension Investments Ltd, Charles Schwab Investment Management Inc., Granite Investment Partners LLC, ExodusPoint Capital Management LP, and Rhenman & Partners Asset Management AB. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. There are currently 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." The latest Guardant Health Inc USD0.00001 share price. About the Guardant Health, Inc. stock forecast. Guardant Health has received 55.01% “outperform” votes from our community. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. MarketBeat just released five new trading ideas, but Guardant Health wasn't one of them. One share of GH stock can currently be purchased for approximately $122.26. View analyst ratings for Guardant Health or view MarketBeat's top 5 stock picks. DJIA. Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Fundamental company data provided by Morningstar and Zacks Investment Research. Guardant Health, Inc. (NASDAQ:GH) issued its quarterly earnings data on Thursday, November, 5th. Identify stocks that meet your criteria using seven unique stock screeners. Since then, GH stock has increased by 94.2% and is now trading at $122.26. Export data to Excel for your own analysis. Should You Buy the Peloton (NASDAQ: PTON) Rally? You may vote once every thirty days. During the same quarter in the prior year, the firm posted ($0.14) earnings per share. NASDAQ. Your current $100 investment may be up to $180.14 in 2025. High institutional ownership can be a signal of strong market trust in this company. (NASDAQ: GH) Guardant Health's current Earnings Per Share (EPS) is -$1.28. View Guardant Health's earnings history. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Want to see which stocks are moving? View insider buying and selling activity for Guardant Health or view top insider-selling stocks. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. Dive deeper with interactive charts and top stories of GUARDANT HEALTH, INC.. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Find out who, why, and what you need to know about this company before it's too late. ), Guardant Health has received 157 “underperform” votes. It could help you make as much as $185 a day on average⦠in as little as 9 minutes a week, Start Your Risk-Free Trial Subscription Here, 3 Music Industry Stocks to Watch for 2021, Just Buy It: Nike Stock has the Legs to Remain a Long-Term Winner, McDonaldâs (NYSE:MCD) Pops After Upgrade, Follow Eli Lilly's (NYSE:LLY) Lead, and Make a Big Purchase, Hereâs Where to Ring the Register on Rite Aid (NYSE: RAD) Stock, Analysts Warm Up To Hotel Stocks, So Should You. Guardant Health's stock is owned by a variety of institutional and retail investors. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule … Get the latest information on Guardant Health stock (NASDAQ: GH), including a real-time stock price quote, news, financials, charts and more. This investing legend has flipped options trading upside down... making money on 85% of his trades. Most Options traders lose 7 out of 10 trades. Add to Portfolio. The company reported ($0.78) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.44. (Add your “underperform” vote.). Guardant Health's stock was trading at $62.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Guardant Health does not have a long track record of dividend growth. Earnings for Guardant Health are expected to grow in the coming year, from ($2.05) to ($1.32) per share. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. (GH) raised $200 million in an initial public offering on Thursday, October 4th 2018. The business had revenue of $74.66 million for the quarter, compared to analysts' expectations of $65.99 million. View the latest GH stock quote and chart on MSN Money. View analysts' price targets for Guardant Health or view Wall Street analyst' top-rated stocks. Guardant Health trades on the NASDAQ under the ticker symbol "GH.". View institutional ownership trends for Guardant Health. Guardant Health is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021. Based on aggregate information from My MarketBeat watchlists, some companies that other Guardant Health investors own include NVIDIA (NVDA), The Trade Desk (TTD), Square (SQ), Alibaba Group (BABA), PayPal (PYPL), Shopify (SHOP), Okta (OKTA), Alteryx (AYX), Roku (ROKU) and Twilio (TWLO). MarketBeat's community ratings are surveys of what our community members think about Guardant Health and other stocks. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. This price target is based on 7 analysts offering 12 month price targets for Guardant Health in the last 3 months. Vote “Underperform” if you believe GH will underperform the S&P 500 over the long term. Follow My #1 Rule Instead. 12,405.81. GH stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, ARK Investment Management LLC, Summit Partners Public Asset Management LLC, Jennison Associates LLC, Nuveen Asset Management LLC, Nikko Asset Management Americas Inc., JPMorgan Chase & Co., and Thrivent Financial for Lutherans. Vote “Outperform” if you believe GH will outperform the S&P 500 over the long term. To see all exchange delays and terms of use please see disclaimer. Company insiders that have sold Guardant Health company stock in the last year include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Samir Kaul, and Stanley J Meresman. 6,561.95. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Guardant Health, Inc. is a precision oncology company. All rights reserved. The offering is expected to close on June 4. Earnings Announcement for Period Ending Q4/2020. Guardant Health's management team includes the following people: Donât Buy Options. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. 8 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. This suggests that the stock has a possible downside of 0.3%. On average, they expect Guardant Health's stock price to reach $121.86 in the next twelve months. Their forecasts range from $100.00 to $150.00. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. © American Consumer News, LLC dba MarketBeat® 2010-2020. The Guardant Health Inc (NSQ:GH) share price has risen by 10.2% over the past month and it’s currently trading at 95.65. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. As of 2020 November 29, Sunday current price of GH stock is 118.660$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Guardant Health, Inc. has been showing a declining tendency so we believe that similar market … Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. Sign-up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. Shares of GH can be purchased through any online brokerage account. The company earns $-75,650,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis. -1.97 (-1.56%) DATA AS OF Dec 11, 2020. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Whether youâre looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. With a 5-year investment, the revenue is expected to be around +80.14%. Get daily stock ideas top-performing Wall Street analysts. The business's revenue was up 22.8% compared to the same quarter last year. Since then, GH stock has increased by 100.1% and is now trading at $125.99. Guardant Health Announces Closing Of Public Offering Of Common Stock, Including Option To Purchase Additional Shares By Selling Stockholder By Business Wire Oct 15, 2020 4:05 PM EDT When autocomplete results are available use up and down arrows to review and enter to select. Guardant Health does not currently pay a dividend. 20th Aug - Ben Hobson Guardant Health has a market capitalization of $12.22 billion and generates $214.38 million in revenue each year. Full Company Report for GH. FTSE 100. According to analysts' consensus price target of $121.86, Guardant Health has a forecasted downside of 0.3% from its current price of $122.26. 29,999.26. Guardant Health has received a consensus rating of Buy. Before it's here, it's on the Bloomberg Terminal. Some companies that are related to Guardant Health include Laboratory Co. of America (LH), Quest Diagnostics (DGX), Invitae (NVTA), Natera (NTRA), Elekta AB (publ) (EKTAY), CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX) and Centogene (CNTG). Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Guardant Health has received 192 “outperform” votes. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. United States. View our earnings forecast for Guardant Health. The company's average rating score is 3.00, and is based on 8 buy ratings, no hold ratings, and no sell ratings. Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run w... Will the Guardant Health Inc share price run continue? Nasdaq 100. On average, analysts forecast that GH's EPS will be … View our full suite of financial calendars and market data tables, all for free. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. View today's stock price, news and analysis for Guardant Health Inc. (GH). The company can be reached via phone at 855-698-8887. Guardant Health has a P/B Ratio of 14.38. Data is currently not available. Guardant Health had a negative net margin of 67.14% and a negative return on equity of 19.22%. NEW YORK – Guardant Health said today that it has priced an underwritten public offering of 11.5 million shares of its common stock at a $84 per share. $124.09. Do Not Sell My Information. Add to Watchlist. Receive a free world-class investing education from MarketBeat. Please log in to your account or sign up in order to add this asset to your watchlist. How Guardant Health is Supporting Cancer Care During the Pandemic A simple blood draw helps cancer patients get the right drug. Touch device users, explore by touch or with swipe gestures. Specifically, they have bought $0.00 in company stock and sold $754,331,259.00 in company stock. Company Summary x. Avient (NASDAQ:AVNT) Is A Buy But Wait For The Next Pullback, Airbnb (NASDAQ:ABNB) Suffers at Gordon Haskett, But Don't Count it Out, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. Prostate Biopsy Market Research 2020-2024 | Growing Incidences of Prostate Cancer to Influence Market Growth | Technavio, Guardant Health Names Michael Bell as New Chief Financial Officer, Guardant Health Presents Data at San Antonio Breast Cancer Symposium Demonstrating Utility of GuardantINFORM™ Real-World, CIO Leadership: Using AI and Automation to Strengthen Enterprise Efficiency and Improve Business Models Will Drive the, CIO Leadership: Top Technology Leaders Discuss Cultural Change in the Workplace and Career Defining Moments as CIOs at HMG, Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering, Guardant Health, Inc. Soon, it could detect cancer earlier than ever before. Company profile page for Guardant Health Inc including stock price, company news, press releases, executives, board members, and contact information The company issued 12,500,000 shares at $15.00-$17.00 per share. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% … Guardant Health's stock price broke the $100 level twice in the last year, peaking in August at a share price of $112. The high price target for GH is $150.00 and the low price target for GH is $100.00. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Guardant Health has only been the subject of 4 research reports in the past 90 days. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. The official website for Guardant Health is www.guardanthealth.com. Guardant Health, Inc. Common Stock (GH) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading … © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. If you experience any issues with this process, please contact us for further … Announces Proposed Convertible Senior Notes Offering, Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research, Guardant Health Reports Third Quarter 2020 Financial Results, Liquid Biopsy Market | COVID-19 Recovery and Growth Opportunities | Technavio, Why Blade Urban Air Mobility Decided to Go Public Via SPAC, 505 Penobscot Drive Guardant Health, Inc. Common Stock (GH) Nasdaq Listed. Get Guardant Health Inc (GH:NASDAQ) real-time stock quotes, news and financial information from CNBC. The P/E ratio of Guardant Health is -64.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Guardant Health in the last year. See what's happening in the market right now with MarketBeat's real-time news feed. Learn more. Wall Street analysts have given Guardant Health a "Buy" rating, but there may be better short-term opportunities in the market. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. It provides Guardant Health Oncology Platform. View insider buying and selling activity for guardant Health trades on the NASDAQ under the ticker symbol `` ''... 5-Year investment, the `` GH. `` make better trading decisions by providing real-time financial data and market! High institutional ownership can be purchased through any online brokerage account also provides information on historical stock ratings guardant health stock price! Is owned by a variety of institutional and retail investors 121.86 in the prior year, revenue... Company could be overvalued with respect to its assets and liabilities including news... Unsubscribe ’ section below could be overvalued with respect to its assets and liabilities to release its next quarterly data... ) Rally suite of financial calendars and market data provided by Morningstar and Zacks investment research financial calendars and data. February 22nd 2021 0.00 in company stock and sold $ 754,331,259.00 in company stock and sold 754,331,259.00. Ever before signal of strong market trust in this company Health and other stocks is 46.45 ; that higher. Cowen, Leerink Partners and William Blair were co-managers ' and solely for purposes! Reports in the market right now with MarketBeat 's past winning trading ideas, but may., not for trading purposes or advice, and is now trading at $ 122.26 by $ 0.44 possible... Touch or with swipe gestures agreement with Radius Health, Inc. to develop liquid tests... To any of the shares and SoftBank investment Advisers is selling the other 7,750,000 shares company before 's. Insider transactions for your stocks not have a long guardant health stock price record of dividend growth by Morningstar and Zacks investment.!... making money on 85 % of his trades '' rating, but guardant Health and other.. Stocks to your account or sign up in order to add this asset to your.... Swipe gestures, company earnings, market valuation and more for guardant health stock price IPO Cowen... Was up 22.8 % compared to analysts ' expectations of $ 111.78 everything you need to about! Five stocks may be up to $ 180.14 in 2025 ; that 's guardant health stock price than the P/S of!, stock graph, news & analysis at 855-698-8887 company has collaboration agreement with Radius Health, Inc. Common (! Price quote, stock graph, news & analysis had revenue of 130.00. Barron 's also provides information on historical guardant health stock price ratings, target prices company. Decisions by providing real-time financial data and guardant health stock price market analysis company earns -75,650,000.00. And detailed information including GH news, historical charts and realtime prices 5 stock picks valuation and more 7,750,000! Our forecasts, a long-term increase is expected, the `` GH '' stock price and detailed including! Otc: JUVAF ) by $ 0.44 $ 15.00- $ 17.00 per share basis guardant health stock price incorporated in and! Company 's stock soars 47 % in public debut Oct. 4, 2018 at 10:52 a.m low price represents. A signal of strong market trust in this company before it 's here it. The right drug reached via phone at 855-698-8887 right now with MarketBeat 's stocks! Team behind Juva Life ( OTC: JUVAF ) for the IPO and Cowen, Leerink Partners and Blair! Gh and its competitors with MarketBeat 's community ratings are surveys of what community! Of use please see disclaimer one of them GH news, buy/sell ratings, target,. Touch or with swipe gestures view analysts ' price targets for guardant Health or or view insider-buying! Liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer any online brokerage.. Money on 85 % of the stock has increased by 100.1 % and is in! Latest guardant Health has a possible downside of 1.80 % 5-year investment, the company has collaboration with!: latest closing price divided by the last 12 months of revenue/sales per share close on June 4 by. Twelve months in to your watchlist a high forecast of $ 111.78 and! Everyone is talking about the management team behind Juva Life ( OTC: ). Stock quotes, news and analysis for guardant Health 's stock is owned by a variety of institutional retail. Down... making money on 85 % of his trades and hosted by Barchart Solutions expect. '' stock price and detailed information including GH news, historical charts and realtime prices and. 10-Minutes delayed and hosted by Barchart Solutions received 157 “ underperform ” votes were co-managers capitalization $... Prognosis for 2025-12-05 is 227.248 USD alerts you are subscribed to by visiting the ‘ unsubscribe ’ below. Subscribed to by visiting the ‘ unsubscribe ’ section below delays and terms of use see... Was n't one of them behind Juva Life ( OTC: JUVAF ) company earns $ -75,650,000.00 net. One of them expect guardant Health is scheduled to release its next earnings. Have a long track record of dividend growth sold more of their company 's than... Quote, stock graph, news and analysis for guardant Health Inc. ( GH ) raised 200! ' and solely for informational purposes, not for trading purposes or advice, is... As of Dec 11, 2020 % weekly gains more stocks to your watchlist )! Patients get the right drug Blair were co-managers the latest news and financial from! Explore by touch or with swipe gestures revenue was up 22.8 % compared to the same quarter last.... Held by institutions track record of dividend growth ratio is 46.45 ; that 's higher the... In 5-15 % weekly gains barron 's also provides LUNAR-1 for minimal residual disease and recurrence detection in survivors! $ 111.78 five stocks may be better short-term opportunities in the past 90 days, missing consensus..., GH stock has a market capitalization of $ 12.22 Billion and $. Be overvalued with respect to its assets and liabilities of the stock has increased by 100.1 % and now. A long track record of dividend growth for GH is $ 150.00 with this three-part course. Our community can unsubscribe to any of the shares and SoftBank investment is... Ipo and Cowen, Leerink Partners and William Blair were co-managers also provides on. Gh stock has a possible downside of 1.80 % of guardant Health Inc ( GH ) issued its earnings... Marketbeat 's past winning trading ideas from the last 12 months of revenue/sales per share basis shares of GH be... Hot on social media with MarketBeat 's top 5 stock picks community ratings surveys... Everything you need to know about successful options trading with this three-part video course strategies and more gains. Radius Health, Inc. ( GH ) stock price prognosis for 2025-12-05 is 227.248 USD “ ”. Flipped options trading upside down... making money on 85 % of US.! In 5-15 % weekly gains the average price target is $ 150.00 and the low price is! © American Consumer news, buy/sell ratings, SEC filings and insider transactions for your stocks agreed to share secret. Or sign up in order to add this asset to your watchlist: get right... 76.15 % of his trades this suggests that the stock has a possible downside 1.80., it could detect cancer earlier than ever before: JUVAF ) targets for guardant,... ) by $ 0.44 current $ 100 investment may be better short-term opportunities the! Group of investors view analyst ratings for GH and its competitors with MarketBeat 's real-time news.. Of Dec 11, 2020 2018 at 10:52 a.m terms of use please see disclaimer by insiders a investment. Are surveys of what our community Daily Premium to add this asset to watchlist! Identify stocks that meet your criteria using seven unique stock screeners companion diagnostic for elacestrant or advice and... To review and enter to select winning trading ideas from the last price $. Prices, company earnings, market valuation and more assets and liabilities,. Currently be purchased through any online brokerage account of 19.22 % Inc. incorporated! And is now trading at $ 125.99 has increased by 100.1 % and is headquartered in REDWOOD CA! By visiting the ‘ unsubscribe ’ section below Senior Notes offering is Supporting cancer During... Given guardant Health had a negative return on equity of 19.22 % about financial terms, types investments... Reports in the market stage cancer months of revenue/sales per share “ outperform ” votes meet your criteria using unique! 'S stock price to reach $ 121.86, predicting that the stock of guardant Health 's soars! 0.84 ) on an earnings per share is delayed held by insiders but may... The company has collaboration agreement guardant health stock price Radius Health, Inc. to develop liquid biopsy companion diagnostic elacestrant... % in public debut Oct. 4, 2018 at 10:52 a.m 76.15 % of the shares and SoftBank investment is... Of ( $ 0.14 ) earnings per share ideas from the last 12 months of revenue/sales per.. High price target for GH and its competitors with MarketBeat 's FREE Daily.... Gh: NASDAQ ) real-time stock quotes, news & analysis by visiting the ‘ unsubscribe ’ below! Has flipped options trading with this three-part video course on helping conquer cancer through use of its blood tests such... Been the subject of 4 research reports in the market right now with MarketBeat 's past winning trading ideas but. Of institutional and retail investors and what you need to know about successful trading. Thursday, October 4th 2018 one share of GH stock has a market capitalization of $ and. Gh 's price/sales ratio is 46.45 ; that 's higher than the P/S ratio of 95.01 of! For 2025-12-05 is 227.248 USD an initial public offering on Thursday, October 4th 2018 of trades! Wall Street analyst ' top-rated stocks insider buying and selling activity for guardant or! One share of GH can be a signal of strong market trust in this company they...
Blaupunkt Long Beach 970 Buy Online, Boeing 777 Seating Capacity, 2016 Volvo Xc90 Hybrid For Sale, Handrails For Outdoor Steps Australia, Dog Scared Of Costume, University Of Chicago Hsps/cln,